These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7585595

  • 1. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
    Choi CW, Lang L, Lee JT, Webber KO, Yoo TM, Chang HK, Le N, Jagoda E, Paik CH, Pastan I.
    Cancer Res; 1995 Nov 15; 55(22):5323-9. PubMed ID: 7585595
    [Abstract] [Full Text] [Related]

  • 2. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Cancer Res; 1997 May 15; 57(10):1955-61. PubMed ID: 9157991
    [Abstract] [Full Text] [Related]

  • 3. Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.
    Webber KO, Kreitman RJ, Pastan I.
    Cancer Res; 1995 Jan 15; 55(2):318-23. PubMed ID: 7812965
    [Abstract] [Full Text] [Related]

  • 4. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H, Yoo TM, Kim IS, Kim MK, Le N, Webber KO, Pastan I, Paik CH, Eckelman WC, Carrasquillo JA.
    Cancer Res; 1996 Aug 15; 56(16):3788-95. PubMed ID: 8706025
    [Abstract] [Full Text] [Related]

  • 5. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H, Sun BF, Yoo TM, Le N, Kim MK, Paik CH, Pastan I, Waldmann TA, Carrasquillo JA.
    J Nucl Med; 1999 Aug 15; 40(8):1381-91. PubMed ID: 10450692
    [Abstract] [Full Text] [Related]

  • 6. Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv.
    Carrasquillo JA, Lang L, Whatley M, Herscovitch P, Wang QC, Pastan I, Eckelman WC.
    Cancer Res; 1998 Jun 15; 58(12):2612-7. PubMed ID: 9635587
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTc.
    Kim IS, Yoo TM, Kobayashi H, Kim MK, Le N, Wang QC, Pastan I, Carrasquillo JA, Paik CH.
    Bioconjug Chem; 1999 Jun 15; 10(3):447-53. PubMed ID: 10346877
    [Abstract] [Full Text] [Related]

  • 9. Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H, Han ES, Kim IS, Le N, Rajagopal V, Kreitman RJ, Pastan I, Paik CH, Carrasquillo JA.
    Nucl Med Biol; 1998 May 15; 25(4):387-93. PubMed ID: 9639301
    [Abstract] [Full Text] [Related]

  • 10. Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.
    Kobayashi H, Sun BF, Han ES, Kim MK, Le N, Wang QC, Nelson DL, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Jpn J Cancer Res; 1998 Apr 15; 89(4):436-44. PubMed ID: 9617350
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.
    Kobayashi H, Kao CH, Kreitman RJ, Le N, Kim MK, Brechbiel MW, Paik CH, Pastan I, Carrasquillo JA.
    J Nucl Med; 2000 Apr 15; 41(4):755-62. PubMed ID: 10768579
    [Abstract] [Full Text] [Related]

  • 12. Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.
    Wu C, Jagoda E, Brechbiel M, Webber KO, Pastan I, Gansow O, Eckelman WC.
    Bioconjug Chem; 1997 Apr 15; 8(3):365-9. PubMed ID: 9177842
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
    Yoo TM, Chang HK, Choi CW, Webber KO, Le N, Kim IS, Eckelman WC, Pastan I, Carrasquillo JA, Paik CH.
    J Nucl Med; 1997 Feb 15; 38(2):294-300. PubMed ID: 9025758
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 15. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
    Kuan CT, Reist CJ, Foulon CF, Lorimer IA, Archer G, Pegram CN, Pastan I, Zalutsky MR, Bigner DD.
    Clin Cancer Res; 1999 Jun 15; 5(6):1539-49. PubMed ID: 10389943
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW.
    Bioconjug Chem; 1999 Jun 15; 10(1):103-11. PubMed ID: 9893971
    [Abstract] [Full Text] [Related]

  • 17. Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model.
    Garg PK, Garg S, Bigner DD, Zalutsky MR.
    Cancer Res; 1992 Sep 15; 52(18):5054-60. PubMed ID: 1516061
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M, Endo K, Watanabe Y, Saga T, Sakahara H, Konishi J, Yamamuro T, Toyama S.
    Cancer Res; 1989 Apr 01; 49(7):1752-7. PubMed ID: 2924318
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Reiter Y, Pai LH, Brinkmann U, Wang QC, Pastan I.
    Cancer Res; 1994 May 15; 54(10):2714-8. PubMed ID: 8168102
    [Abstract] [Full Text] [Related]

  • 20. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.